[HTML][HTML] Evaluation of the clinical performance of a novel chemiluminescent immunoassay for detection of anticardiolipin and anti-beta2-glycoprotein 1 antibodies in …
S Zhang, Z Wu, P Li, Y Bai, F Zhang, Y Li - Medicine, 2015 - journals.lww.com
Detection of antiphospholipid antibodies represents the first-line approach for diagnosis of
antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a …
antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a …
[引用][C] Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in …
S Zhang, Z Wu, P Li, Y Bai, F Zhang, Y Li - Medicine, 2015 - cir.nii.ac.jp
Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for
Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the Diagnosis of …
Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the Diagnosis of …
Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the …
S Zhang, Z Wu, P Li, Y Bai, F Zhang, Y Li - Medicine, 2015 - europepmc.org
Detection of antiphospholipid antibodies represents the first-line approach for diagnosis of
antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a …
antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a …
Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the …
S Zhang, Z Wu, P Li, Y Bai, F Zhang, Y Li - Medicine, 2015 - pubmed.ncbi.nlm.nih.gov
Detection of antiphospholipid antibodies represents the first-line approach for diagnosis of
antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a …
antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a …
[HTML][HTML] Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies …
S Zhang, Z Wu, P Li, Y Bai, F Zhang, Y Li - Medicine, 2015 - ncbi.nlm.nih.gov
Detection of antiphospholipid antibodies represents the first-line approach for diagnosis of
antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a …
antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a …
[PDF][PDF] Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in …
S Zhang, Z Wu, P Li, Y Bai, F Zhang, Y Li - Medicine, 2015 - scienceopen.com
Detection of antiphospholipid antibodies represents the first-line approach for diagnosis of
antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a …
antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a …
Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the …
S Zhang, Z Wu, P Li, Y Bai, F Zhang, Y Li - Medicine, 2015 - europepmc.org
Detection of antiphospholipid antibodies represents the first-line approach for diagnosis of
antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a …
antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a …